申请人:Evans Richard
公开号:US20080182874A1
公开(公告)日:2008-07-31
The invention provides compounds of formula (I), or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof, in which A, n, p, q, R
1
, R
2
, R
3
and R
4
are as defined in the specification; a process for their preparation; pharmaceutical compositions containing them; and their use in therapy.
该发明提供了式(I)的化合物,或其药学上可接受的盐或体内可水解的酯,其中A、n、p、q、R1、R2、R3和R4如规范中所定义;它们的制备方法;包含它们的药物组合物;以及它们在治疗中的应用。